相似文献
1
Establishment of an International Reference Reagent for standardization of von Willebrand factor binding to recombinant glycoprotein Ib (VWF:GPIbM and VWF:GPIbR): Official Communication of the SSC.
J Thromb Haemost. 2019 Jun;17(6):1003-1005. doi: 10.1111/jth.14429. Epub 2019 May 17.
2
A comparative analysis of different automated von Willebrand factor glycoprotein Ib-binding activity assays in well typed von Willebrand disease patients.
J Thromb Haemost. 2018 Jul;16(7):1268-1277. doi: 10.1111/jth.14145. Epub 2018 Jun 6.
3
Laboratory Testing for von Willebrand Factor Activity by Glycoprotein Ib Binding Assays (VWF:GPIb).
Methods Mol Biol. 2017;1646:453-460. doi: 10.1007/978-1-4939-7196-1_33.
4
Clinically relevant differences between assays for von Willebrand factor activity.
J Thromb Haemost. 2018 Dec;16(12):2413-2424. doi: 10.1111/jth.14319. Epub 2018 Nov 20.
5
Diagnosis or Exclusion of von Willebrand Disease Using Laboratory Testing.
Methods Mol Biol. 2017;1646:391-402. doi: 10.1007/978-1-4939-7196-1_29.
6
Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
Br J Haematol. 2006 Jun;133(6):655-63. doi: 10.1111/j.1365-2141.2006.06095.x.
7
Laboratory Testing for von Willebrand Factor Activity by a Glycoprotein Ib-Binding Assay (VWF:GPIbR): HemosIL von Willebrand Factor Ristocetin Cofactor Activity on ACL TOP.
Methods Mol Biol. 2023;2663:669-677. doi: 10.1007/978-1-0716-3175-1_44.
8
Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD.
Blood. 2011 Feb 10;117(6):e67-74. doi: 10.1182/blood-2010-08-299016. Epub 2010 Dec 10.
9
Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
Circ Res. 2009 Dec 4;105(12):1177-85. doi: 10.1161/CIRCRESAHA.109.204669. Epub 2009 Oct 29.
10
A new mutation, S1285F, within the A1 loop of von Willebrand factor induces a conformational change in A1 loop with abnormal binding to platelet GPIb and botrocetin causing type 2M von Willebrand disease.
Br J Haematol. 2003 Feb;120(4):643-51. doi: 10.1046/j.1365-2141.2003.04168.x.
引用本文的文献
1
Case-based discussion on the implications of exogenous estrogens in hemostasis and thrombosis: the hematologist's view.
Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):152-157. doi: 10.1182/hematology.2019000022.
本文引用的文献
1
An international collaborative study to compare different von Willebrand factor glycoprotein Ib binding activity assays: the COMPASS-VWF study.
J Thromb Haemost. 2018 Aug;16(8):1604-1613. doi: 10.1111/jth.14206. Epub 2018 Jul 19.
2
Evaluation of a von Willebrand factor three test panel and chemiluminescent-based assay system for identification of, and therapy monitoring in, von Willebrand disease.
Thromb Res. 2016 May;141:202-11. doi: 10.1016/j.thromres.2015.12.010. Epub 2015 Dec 17.
3
Platelet-dependent von Willebrand factor activity. Nomenclature and methodology: communication from the SSC of the ISTH.
J Thromb Haemost. 2015 Jul;13(7):1345-50. doi: 10.1111/jth.12964. Epub 2015 May 9.
4
Diagnostic approach to von Willebrand disease.
Blood. 2015 Mar 26;125(13):2029-37. doi: 10.1182/blood-2014-08-528398. Epub 2015 Feb 23.
5
Towards improved diagnosis of von Willebrand disease: comparative evaluations of several automated von Willebrand factor antigen and activity assays.
Thromb Res. 2014 Dec;134(6):1292-300. doi: 10.1016/j.thromres.2014.09.024. Epub 2014 Sep 28.
6
Performance evaluation and multicentre study of a von Willebrand factor activity assay based on GPIb binding in the absence of ristocetin.
Blood Coagul Fibrinolysis. 2014 Dec;25(8):860-70. doi: 10.1097/MBC.0000000000000169.
7
Laboratory aspects of von Willebrand disease: test repertoire and options for activity assays and genetic analysis.
Haemophilia. 2014 May;20 Suppl 4(0 4):65-70. doi: 10.1111/hae.12410.
8
Comparison of a new chemiluminescent immunoassay for von Willebrand factor activity with the ristocetin cofactor-induced platelet agglutination method.
Haemophilia. 2013 Nov;19(6):920-5. doi: 10.1111/hae.12203. Epub 2013 Jun 4.
9
A comparative evaluation of a new automated assay for von Willebrand factor activity.
Haemophilia. 2013 Mar;19(2):338-42. doi: 10.1111/hae.12064. Epub 2012 Dec 4.
10
Value assignment of the WHO 6th International Standard for blood coagulation factor VIII and von Willebrand factor in plasma (07/316).
J Thromb Haemost. 2011 Oct;9(10):2100-2. doi: 10.1111/j.1538-7836.2011.04471.x.
Zotero 插件